Drugs to reduce body weight were awarded the “Product of the Year 2026” award
November 12, 2026 in the Moscow space Connect was held the ceremony of awarding the 28th national award “Product of the year 2026”

On November 12, 2026, the ceremony of awarding the 28th national award “Product of the Year 2026” took place in the Moscow Connect space. GEROPHARM has won two awards in the category “Medical preparations and health products”.
This is the first case when the winners were funds to combat overweight, writes newstula.ru.
Sejaro won the Innovation nomination. The drug combines a double effect on hormonal receptors (decreased appetite, slowing the emptying of the stomach, prolonging the feeling of satiety) with a digital service - the Stroynee application, which collects information about the drug, training blocks and a diary of injections. According to DSM Group, in the first seven months of 2026 it was the fastest growing brand of the Russian pharmacy market.
“Semavik Next” received the award in the category “Consumer confidence”. According to RNC Pharma, for eight months of 2026, the Semavik brand occupied more than half of the market of this molecule in physical terms, and the Semavik Next line was the leader in sales in the category.
The award covers more than 60 categories and acts as a marker of product demand. The ceremony was supported by the National Trade Association. General Director of GEROPHARM Peter Rodionov said that the award is a recognition of the work of the team and the trust of doctors. He stressed that the company will remain focused on product availability and improving the user experience.

